ZFIN ChEBI: 1,3-diglyceride

Relationships

is a type of: diglyceride

diglyceride Show first 5 Terms
has subtype: (2R)-2-Hydroxy-3-(octadecanoyloxy)propyl (15Z)-tetracos-15-enoate (2R)-2-Hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyloxy]propyl (11Z)-icos-11-enoate (2R)-2-Hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyloxy]propyl (13Z)-docos-13-enoate (2R)-2-Hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyloxy]propyl tetracosanoate (2R)-2-Hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl (13Z)-docos-13-enoate ... Show All 115 Terms

(2R)-2-Hydroxy-3-(octadecanoyloxy)propyl (15Z)-tetracos-15-enoate (2R)-2-Hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyloxy]propyl (11Z)-icos-11-enoate (2R)-2-Hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyloxy]propyl (13Z)-docos-13-enoate (2R)-2-Hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyloxy]propyl tetracosanoate (2R)-2-Hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl (13Z)-docos-13-enoate (2R)-2-Hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl (15Z)-tetracos-15-enoate (2R)-3-(Hexadecanoyloxy)-2-hydroxypropyl (13Z,16Z)-docosa-13,16-dienoate 1,3-di-(10Z-heptadecenoyl)-glycerol 1,3-diacyl-sn-glycerol 1,3-dilinolenoylglycerol 1,3-dilinoleoylglycerol 1,3-dioctanoylglycerol 1,3-dioleoylglycerol 1,3-dipalmitoleoylglycerol 1,3-dipalmitoylglycerol 1-arachidonoyl-3-oleoylglycerol 1-capryloyl-3-oleoylglycerol 1-decanoyl-3-oleoylglycerol 1-lauroyl-3-oleoylglycerol 1-linolenoyl-3-oleoylglycerol 1-myristoyl-3-oleoylglycerol 1-oleoyl-3-linoleoylglycerol 1-oleoyl-3-palmitoylglycerol 1-palmitoyl-3-linoleoylglycerol 1-palmitoyl-3-stearoyl-sn-glycerol 1-stearoyl-3-oleoylglycerol 3-(Acetyloxy)-2-hydroxypropyl icosanoate 3-(Acetyloxy)-2-hydroxypropyl octadecanoate Alpha:alpha-Diolein DG(8:0/0:0/10:0) DG(8:0/0:0/16:0) DG(8:0/0:0/19:0) DG(10:0/0:0/14:0) DG(10:0/0:0/15:0) DG(14:0/0:0/14:0) (d5) DG(14:0/0:0/17:0) DG(14:0/0:0/20:0) DG(14:0/0:0/22:1n9) DG(14:0/0:0/22:6n3) DG(14:1n5/0:0/22:5n3) DG(14:1n5/0:0/22:5n6) DG(15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) DG(15:0/0:0/22:6n3) DG(15:0/0:0/a-17:0) DG(15:0/0:0/i-17:0) DG(16:0/0:0/20:1n9) DG(16:0/0:0/22:4n6) DG(16:0/0:0/22:6n3) DG(16:0/0:0/i-16:0) DG(16:1n7/0:0/22:5n3) DG(16:1n7/0:0/22:5n6) DG(16:1n7/0:0/22:6n3) DG(18:0/0:0/14:0) DG(18:0/0:0/18:1n7) DG(18:0/0:0/18:1n9) DG(18:0/0:0/i-14:0) DG(18:1n7/0:0/18:2n6) DG(18:1n7/0:0/22:6n3) DG(18:1n9/0:0/18:2n6) DG(18:1n9/0:0/22:6n3) DG(18:2n6/0:0/18:2n6) DG(18:2n6/0:0/18:4n3) DG(18:2n6/0:0/22:5n3) DG(18:2n6/0:0/22:5n6) DG(18:2n6/0:0/22:6n3) DG(18:3n6/0:0/22:4n6) DG(19:0/0:0/13:0) DG(19:0/0:0/a-13:0) DG(19:0/0:0/i-13:0) DG(20:0/0:0/12:0) DG(20:0/0:0/16:1n7) DG(20:0/0:0/18:2n6) DG(20:0/0:0/18:4n3) DG(20:0/0:0/22:6n3) DG(20:0/0:0/i-12:0) DG(20:1n9/0:0/18:3n3) DG(20:1n9/0:0/18:3n6) DG(20:1n9/0:0/22:5n3) DG(20:1n9/0:0/22:5n6) DG(20:1n9/0:0/22:6n3) DG(20:2n6/0:0/22:5n3) DG(20:2n6/0:0/22:5n6) DG(20:3n6/0:0/22:4n6) DG(20:3n9/0:0/22:4n6) DG(20:4n3/0:0/22:6n3) DG(20:4n6/0:0/22:2n6) DG(20:4n6/0:0/22:6n3) DG(20:5n3/0:0/22:5n3) DG(20:5n3/0:0/22:6n3) DG(22:0/0:0/10:0) DG(22:0/0:0/14:1n5) DG(22:1n9/0:0/20:5n3) DG(22:2n6/0:0/20:4n3) DG(22:2n6/0:0/20:5n3) DG(22:4n6/0:0/18:3n3) DG(22:5n6/0:0/20:5n3) DG(24:0/0:0/22:5n6) DG(a-15:0/0:0/17:0) DG(a-15:0/0:0/a-17:0) DG(i-15:0/0:0/a-17:0) DG(i-15:0/0:0/i-17:0) DG(i-16:0/0:0/16:0) DG(i-16:0/0:0/i-16:0) DG(i-18:0/0:0/14:0) DG(i-18:0/0:0/i-14:0) DG(i-19:0/0:0/13:0) DG(i-19:0/0:0/a-13:0) DG(i-19:0/0:0/i-13:0) DG(i-20:0/0:0/12:0) DG(i-20:0/0:0/i-12:0) DG(i-22:0/0:0/10:0) DG(i-24:0/0:0/8:0) diacylglycerol (18:1/0:0/18:1) diacylglycerol(18:2/0:0/18:2) diacylglycerol(22:6n3/0:0/22:6n3) Show first 5 Terms

Phenotype

Phenotype resulting from 1,3-diglyceride

Phenotype where environments contain 1,3-diglyceride

Phenotype modified by environments containing 1,3-diglyceride

Human Disease Model